Amicus Therapeutics Announces Conference Participation for Investors

Author: Owen Jenkins Updated: 10-31-2025 07:33 AM

Upcoming Investor Conferences for Amicus Therapeutics

Amicus Therapeutics (NASDAQ: FOLD) proudly announces that management will engage in several key presentations at esteemed investor conferences this November. These events grant investors invaluable insights into the company's direction and innovations.

Details of the Conferences

The first important session will be held during the UBS Global Healthcare Conference. This event takes place on November 10, where the management team is scheduled to speak at 2:45 PM ET. Following that, the Jefferies Global Healthcare Conference will showcase Amicus on November 18, with their presentation set for 4:30 PM GMT. These gatherings provide a platform to discover more about the company's growth and commitment to advancing rare disease therapies.

Accessing Live Webcasts

A live audio webcast of each presentation will be available, allowing interested parties to tune in remotely. These webcasts offer an opportunity for broader engagement, proving that even those unable to attend the conferences in person can stay informed. More streaming details can be found on the Amicus Therapeutics corporate website.

Commitment to Rare Diseases

Amicus Therapeutics is a dedicated biotechnology company focused on developing novel therapies for patients dealing with rare diseases. Their commitment shows through their pipeline of innovative treatments aimed at significantly improving the quality of life for affected individuals. Amicus continually strives to contribute valuable solutions to the healthcare field by focusing on unmet medical needs.

What to Expect from Amicus on the Investor Front

As these conferences approach, investors can expect detailed discussions around ongoing projects and future developments at Amicus Therapeutics. The environment at investor conferences provides an interaction space where executives can communicate the passion and dedication behind their biotechnology solutions. This aligns with the company’s ethos of prioritizing patient welfare and the advancement of scientific research.

Contacting Amicus Therapeutics

For further inquiries, investors can reach out to Andrew Faughnan, the Vice President of Investor Relations at Amicus Therapeutics, through the provided email or phone number. Media inquiries can be directed to Brendan McEvoy, the Executive Director of External Communications.

Frequently Asked Questions

What is the main focus of Amicus Therapeutics?

Amicus Therapeutics primarily focuses on developing innovative treatments for rare diseases, aiming to improve the lives of patients.

When will the presentations take place?

The presentations are scheduled for November 10 and November 18 during the UBS and Jefferies Global Healthcare Conferences, respectively.

How can I access the live presentation?

Live presentations can be accessed via the investor section of the Amicus Therapeutics corporate website around the time of the webinars.

Who can I contact for more information?

For investor-related inquiries, you can contact Andrew Faughnan. For media inquiries, reach out to Brendan McEvoy.

What is the stock ticker for Amicus Therapeutics?

The stock ticker for Amicus Therapeutics is FOLD, which can be tracked on NASDAQ.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.